연구동향 분석
박사

Analysis of microRNA expression profiles and targeted inhibition of specific microRNA in Epilepsy : 뇌전증에서 마이크로알엔에이 발현양상 분석 및 선택적 억제 연구

Jangsup Moon 2015년

논문상세정보
인용/피인용
' Analysis of microRNA expression profiles and targeted inhibition of specific microRNA in Epilepsy : 뇌전증에서 마이크로알엔에이 발현양상 분석 및 선택적 억제 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • drug resistant epilepsy
  • epilepsy
  • microrna
  • microrna-21
  • mtor activity
  • mtor inhibitor
  • tuberous sclerosis complex 1
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
205 0

0.0%

' Analysis of microRNA expression profiles and targeted inhibition of specific microRNA in Epilepsy : 뇌전증에서 마이크로알엔에이 발현양상 분석 및 선택적 억제 연구' 의 참고문헌

  • Zoncu, R., A. Efeyan and D. M. Sabatini (2010). "mTOR: from growth signal integration to cancer, diabetes and ageing." Nature reviews Molecular cell biology 12(1): 21-35.
  • Zhao, D., Y. Tu, L. Wan, L. Bu, T. Huang, X. Sun, K. Wang and B. Shen (2013). "In vivo monitoring of angiogenesis inhibition via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer model using bioluminescent imaging." PLoS one 8(8): e71472.
  • Zeng, L.-H., N. R. Rensing and M. Wong (2009). "The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy." The Journal of Neuroscience 29(21): 6964-6972.
  • Zeng, L. H., L. Xu, D. H. Gutmann and M. Wong (2008). "Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex." Annals of neurology 63(4): 444-453.
  • Uhlmann, E. J., M. Wong, R. L. Baldwin, M. L. Bajenaru, H. Onda, D. J. Kwiatkowski, K. Yamada and D. H. Gutmann (2002). "Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures." Annals of neurology 52(3): 285-296.
  • Suh, S. S., J. Y. Yoo, G. J. Nuovo, Y. J. Jeon, S. Kim, T. J. Lee, T. Kim, A. Bakacs, H. Alder, B. Kaur, R. I. Aqeilan, F. Pichiorri and C. M. Croce (2012). "MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme." Proc Natl Acad Sci USA 109(14): 5316-5321.
  • Stenvang, J., A. Petri, M. Lindow, S. Obad and S. Kauppinen (2012). "Inhibition of microRNA function by antimiR oligonucleotides." Silence 3(1): 1.
  • Selcuklu, S. D., M. A. Donoghue and C. Spillane (2009). "miR-21 as a key regulator of oncogenic processes." Biochemical Society Transactions 37(4): 918.
  • Russo, E., R. Citraro, A. Constanti and G. De Sarro (2012). "The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis." Molecular neurobiology 46(3): 662-681.
  • Risbud, R. M., C. Lee and B. E. Porter (2011). "Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus." Brain research 1424: 53-59.
  • Rapoport, A. M., M. E. Bigal, S. J. Tepper and F. D. Sheftell (2004). "Intranasal medications for the treatment of migraine and cluster headache." CNS drugs 18(10): 671-685.
  • Racine, R. J. (1972). "Modification of seizure activity by electrical stimulation: II. Motor seizure." Electroencephalography and clinical neurophysiology 32(3): 281-294.
  • Pillai, R. S. (2005). "MicroRNA function: multiple mechanisms for a tiny RNA?" Rna 11(12): 1753-1761.
  • Peng, J., A. Omran, M. U. Ashhab, H. Kong, N. Gan, F. He and F. Yin (2013). "Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy." Journal of Molecular Neuroscience 50(2): 291-297.
  • Parent, J. M., W. Y. Timothy, R. T. Leibowitz, D. H. Geschwind, R. S. Sloviter and D. H. Lowenstein (1997). "Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus." The Journal of Neuroscience 17(10): 3727-3738.
  • Pan, X., Z.-X. Wang and R. Wang (2010). "MicroRNA-21: a novel therapeutic target in human cancer." Cancer biology & therapy 10(12): 1224-1232.
  • Meikle, L., D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen and D. J. Kwiatkowski (2007). "A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival." The Journal of neuroscience 27(21): 5546-5558.
  • Makeyev, E. V. and T. Maniatis (2008). "Multilevel regulation of gene expression by microRNAs." Science 319(5871): 1789-1790.
  • Liu, D.-Z., Y. Tian, B. P. Ander, H. Xu, B. S. Stamova, X. Zhan, R. J. Turner, G. Jickling and F. R. Sharp (2009). "Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures." Journal of Cerebral Blood Flow & Metabolism 30(1): 92-101.
  • Li, M.-M., T. Jiang, Z. Sun, Q. Zhang, C.-C. Tan, J.-T. Yu and L. Tan (2014). "Genome-wide microRNA expression profiles in hippocampus of rats with chronic temporal lobe epilepsy." Scientific reports 4: 4734.
  • Lewis, B. P., I.-h. Shih, M. W. Jones-Rhoades, D. P. Bartel and C. B. Burge (2003). "Prediction of mammalian microRNA targets." Cell 115(7): 787-798.
  • Lee, S.-T., K. Chu, W.-S. Im, H.-J. Yoon, J.-Y. Im, J.-E. Park, K.-H. Park, K.-H. Jung, S. K. Lee and M. Kim (2011). "Altered microRNA regulation in Huntington's disease models." Experimental neurology 227(1): 172-179.
  • Lee, S.-T., K. Chu, K.-H. Jung, H.-J. Yoon, D. Jeon, K.-M. Kang, K.-H. Park, E.-K. Bae, M. Kim and S. K. Lee (2010). "MicroRNAs induced during ischemic preconditioning." Stroke 41(8): 1646-1651.
  • Lee, S. T., K. Chu, K. H. Jung, J. H. Kim, J. Y. Huh, H. Yoon, D. K. Park, J. Y. Lim, J. M. Kim and D. Jeon (2012). "miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model." Annals of neurology 72(2): 269-277.
  • Krueger, D. A., A. A. Wilfong, K. Holland-Bouley, A. E. Anderson, K. Agricola, C. Tudor, M. Mays, C. M. Lopez, M. O. Kim and D. N. Franz (2013). "Everolimus treatment of refractory epilepsy in tuberous sclerosis complex." Annals of neurology 74(5): 679-687.
  • Kretschmann, A., B. Danis, L. Andonovic, K. Abnaof, M. van Rikxoort, F. Siegel, M. Mazzuferi, P. Godard, E. Hanon and H. Fr hlich (2014). "Different MicroRNA Profiles in Chronic Epilepsy Versus Acute Seizure Mouse Models." Journal of Molecular Neuroscience: 1-14.
  • Krek, A., D. Gr n, M. N. Poy, R. Wolf, L. Rosenberg, E. J. Epstein, P. MacMenamin, I. da Piedade, K. C. Gunsalus and M. Stoffel (2005). "Combinatorial microRNA target predictions." Nature genetics 37(5): 495-500.
  • Kr tzfeldt, J., N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan and M. Stoffel (2005). "Silencing of microRNAs in vivo with ‘antagomirs’." Nature 438(7068): 685-689.
  • Klitgaard, H., A. Matagne, R. Grimee, J. Vanneste-Goemaere and D.-G. Margineanu (2003). "Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy." Seizure 12(2): 92-100.
  • Kim, J.-M., S.-T. Lee, K. Chu, K.-H. Jung, J. H. Kim, J.-S. Yu, S. Kim, S. H. Kim, D.-K. Park and J. Moon (2014). "Inhibition of Let7c MicroRNA Is Neuroprotective in a Rat Intracerebral Hemorrhage Model." PLoS one 9(6): e97946.
  • Jimenez-Mateos, E. M., T. Engel, P. Merino-Serrais, R. C. McKiernan, K. Tanaka, G. Mouri, T. Sano, C. O'Tuathaigh, J. L. Waddington and S. Prenter (2012). "Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects." Nature medicine 18(7): 1087-1094.
  • Jimenez-Mateos, E. M., I. Bray, A. Sanz-Rodriguez, T. Engel, R. C. McKiernan, G. Mouri, K. Tanaka, T. Sano, J. A. Saugstad and R. P. Simon (2011). "miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132." The American journal of pathology 179(5): 2519-2532.
  • Huang, Y., Y. Yang, X. Zhang, X. Yu, Z. Wang and X. Cheng (2013). "MicroRNA-21 gene and cancer." Medical Oncology 30(1): 1-9.
  • Huang, X., H. Zhang, J. Yang, J. Wu, J. McMahon, Y. Lin, Z. Cao, M. Gruenthal and Y. Huang (2010). "Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy." Neurobiology of disease 40(1): 193-199.
  • Hu, K., C. Zhang, L. Long, X. Long, L. Feng, Y. Li and B. Xiao (2011). "Expression profile of microRNAs in rat hippocampus following lithium–pilocarpine-induced status epilepticus." Neuroscience letters 488(3): 252-257.
  • Han, M., M. Liu, Y. Wang, X. Chen, J. Xu, Y. Sun, L. Zhao, H. Qu, Y. Fan and C. Wu (2012). "Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN." PLoS One 7(6): e39520.
  • H bert, S. S. and B. De Strooper (2009). "Alterations of the microRNA network cause neurodegenerative disease." Trends in neurosciences 32(4): 199-206.
  • Galanopoulou, A. S., J. A. Gorter and C. Cepeda (2012). "Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target." Epilepsia 53(7): 1119-1130.
  • Fiore, R., G. Siegel and G. Schratt (2008). "MicroRNA function in neuronal development, plasticity and disease." Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1779(8): 471-478.
  • Engel, J. (2001). "A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology." Epilepsia 42(6): 796-803.
  • Elm n, J., H. Thonberg, K. Ljungberg, M. Frieden, M. Westergaard, Y. Xu, B. Wahren, Z. Liang, H. rum and T. Koch (2005). "Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality." Nucleic acids research 33(1): 439-447.
  • Eacker, S. M., T. M. Dawson and V. L. Dawson (2009). "Understanding microRNAs in neurodegeneration." Nature Reviews Neuroscience 10(12): 837-841.
  • Dhuria, S. V., L. R. Hanson and W. H. Frey (2010). "Intranasal delivery to the central nervous system: mechanisms and experimental considerations." Journal of pharmaceutical sciences 99(4): 1654-1673.
  • Craft, S., L. D. Baker, T. J. Montine, S. Minoshima, G. S. Watson, A. Claxton, M. Arbuckle, M. Callaghan, E. Tsai and S. R. Plymate (2012). "Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial." Archives of neurology 69(1): 29-38.
  • Bushati, N. and S. M. Cohen (2007). "microRNA functions." Annu. Rev. Cell Dev. Biol. 23: 175-205.
  • Buckmaster, P. S., G. F. Zhang and R. Yamawaki (2002). "Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit." The Journal of neuroscience 22(15): 6650-6658.
  • Bethmann, K., C. Brandt and W. L scher (2007). "Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy." Epilepsia 48(4): 816-826.
  • Bateup, H. S., C. A. Johnson, C. L. Denefrio, J. L. Saulnier, K. Kornacker and B. L. Sabatini (2013). "Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis." Neuron 78(3): 510-522.
  • Alvarez-Garcia, I. and E. A. Miska (2005). "MicroRNA functions in animal development and human disease." Development 132(21): 4653-4662.
  • Abs, E., S. M. Goorden, J. Schreiber, I. E. Overwater, M. Hoogeveen-Westerveld, C. F. Bruinsma, E. Aganović, N. Z. Borgesius, M. Nellist and Y. Elgersma (2013). "TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice." Annals of neurology 74(4): 569-579.